Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07652970 · ClinicalTrials.gov registry record · NA

Tele-CE in Severe Stroke

A NA study, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
40
Enrollment target

NCT07652970: Recruiting NA study, sponsored by University of Illinois at Chicago.

NCT07652970 is a NA study that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07652970, a NA study, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The goal of this clinical trial is to determine the effects of home-based cross-education on lower limb neuroplasticity in severe stroke. The main questions the investigators aim to answer are: * What are the effects of home-based cross-education on lower limb neuroplasticity? * What are the effects of home-based cross-education on lower limb function? * Is home-based cross-education feasible to administer and accepted by participants? Participants will take part in ten home-based, remotely supervised sessions, during which participants will either perform unilateral skill and strength training of the unaffected lower limb (Tele-Cross Education or Tele-CE) or cognitive training and unilateral movements of the unaffected lower limb (Tele-control). Each participant will experience measures of brain and spinal activity and motor function testing before and after both sessions (Tele-CE and Tele-control). Each participant will also be asked to fill out a feedback questionnaire to assess acceptability after intervention sessions (Tele-CE and Tele-control).

Primary Outcome

Single-pulse transcranial magnetic stimulation (TMS) will be used to assess the corticomotor excitability from the tibialis anterior muscle. Higher values indicate more corticomotor excitability.

Interventions

  • OTHER Tele-CE
  • OTHER Tele-Control

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-06
Est. Completion 2027-06
Phase NA
University of Illinois at Chicago

430 total trials

What NCT07652970 shows while recruiting

NCT07652970 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Tele-CE is the first listed.

NCT07652970 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07652970 about?

NCT07652970 is a clinical study titled "Tele-CE in Severe Stroke". The goal of this clinical trial is to determine the effects of home-based cross-education on lower limb neuroplasticity in severe stroke. The main questions the investigators aim to answer are: * What are the effects of home-based cross-education on lower limb neuroplasticity? * What are the effec...

What is the current status of trial NCT07652970?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06. Estimated completion is 2027-06.

What interventions are being tested in trial NCT07652970?

The interventions under investigation include: Tele-CE (OTHER), Tele-Control (OTHER).

Who is sponsoring clinical trial NCT07652970?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07652970's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07652970, the US trial registry maintained by the National Library of Medicine. NCT07652970 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.